Imaging of Canine Neoplastic Reproductive Disorders

SIMPLE SUMMARY: The diagnosis of canine reproductive neoplasia remains challenging as none of the routinely performed diagnostic methods appear to have sufficient sensitivity or specificity. In recent years, advanced imaging techniques have been successfully performed in small animals; however, even though the incidence of reproductive neoplasia is high, no data are available on the performance of these techniques. This review evaluates the applicability of various diagnostic imaging modalities in dogs and describes the findings and specific patterns that may characterise different tumour types. Lamentably, some of the advanced imaging techniques have not yet been adopted as first-line diagnostic tools, although it is clear that in the future they will become important methods for the detection of male and female reproductive neoplasia. ABSTRACT: Diagnostic imaging plays an essential role in the diagnosis and management of reproductive neoplasia in dogs and cats. The initial diagnosis, staging, and planning of surgical and radiation treatment and the response to therapy all involve imaging to varying degrees. Routine radiographs, ultrasound, nuclear medicine, and cross-sectional imaging in the form of computed tomography (CT) and magnetic resonance imaging (MRI) are routinely used in canine reproductive disorders. The choice of imaging modality depends on many factors, including the level of referral and the pathological information required. The biological behaviour of the tumour also guides the choice of imaging in cancer staging, and imaging may play an important role in guiding serial tumour biopsy during the course of therapy. The sophistication of imaging modalities is increasing exponentially. Each modality has advantages and disadvantages in terms of cost, availability, sensitivity, specificity, and qualities of anatomic versus functional imaging.